Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods-Reference-Cited by-同舟云学术

Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods

Published:2006-12 Issue:6 Volume:73 Page:629-632
ISSN:1297-319X
Container-title:Joint Bone Spine
language:en
Short-container-title:Joint Bone Spine

Author:

Montastruc Jean-Louis,Sommet Agnès,Lacroix Isabelle,Olivier Pascale,Durrieu Geneviève,Damase-Michel Christine,Lapeyre-Mestre Maryse,Bagheri Haleh

Publisher

Elsevier BV

Subject

Rheumatology

Reference10 articles.

1. Mechanism of action of drug reactions: an overview;Royer;Pharmacoepidemiol. Drug Saf.,1997

2. Les cinq « trop » des essais cliniques: plaidoyer pour une Pharmacoépidémiologie pour tous;Montastruc;Rev Prescr,2006

3. Imputation of the unexpected or toxic effects of drugs: actualization of the method used in France;Begaud;Therapie,1985

4. Nouvelles méthodes d’étude du risque médicamenteux: l’expérience du Centre Midi-Pyrénées de PharmacoVigilance;Montastruc;Bull. Acad. Natl. Med.,2005

5. Under reporting of adverse drug reactions: a systematic review;Hazell;Drug Saf.,2006

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of drug-induced angioedema: a pharmacovigilance study of FDA adverse event reporting system database;Frontiers in Pharmacology;2024-07-16

2. Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis;Pharmaceuticals;2024-07-07

3. Weight gain, gender, and antipsychotics: a disproportionality analysis of the FDA Adverse Event Reporting System database (FAERS);Expert Opinion on Drug Safety;2023-08-21

4. Drug–drug interaction of Nirmatrelvir/ritonavir and tacrolimus: A potential risk disproportionality analysis of nephrotoxicity from COVID-19 reports in FAERS;Expert Opinion on Drug Safety;2023-07-24